Rafael Holdings, Inc. (NYSE:RFL) Sees Significant Drop in Short Interest

Rafael Holdings, Inc. (NYSE:RFL) saw a significant decline in short interest during the month of March. As of March 31st, there was short interest totaling 33,970 shares, a decline of 15.1% from the March 15th total of 40,019 shares. Based on an average trading volume of 59,841 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.1% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Rafael in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Geode Capital Management LLC grew its stake in shares of Rafael by 25.4% during the fourth quarter. Geode Capital Management LLC now owns 445,866 shares of the company’s stock valued at $526,000 after buying an additional 90,417 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Rafael by 10.5% during the third quarter. Vanguard Group Inc. now owns 1,394,726 shares of the company’s stock worth $1,897,000 after purchasing an additional 133,024 shares during the last quarter. Cable Car Capital LP bought a new stake in shares of Rafael during the second quarter worth $173,000. Citadel Advisors LLC lifted its position in shares of Rafael by 132.3% during the third quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock worth $99,000 after purchasing an additional 41,335 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in shares of Rafael during the second quarter worth $50,000. Institutional investors own 11.30% of the company’s stock.

Rafael Stock Up 4.1%

NYSE:RFL traded up $0.05 during mid-day trading on Friday, hitting $1.27. 63,247 shares of the stock traded hands, compared to its average volume of 49,351. The stock has a market capitalization of $66.05 million, a price-to-earnings ratio of -1.61 and a beta of 0.51. Rafael has a 52 week low of $1.12 and a 52 week high of $3.19. The firm’s 50 day moving average is $1.29 and its two-hundred day moving average is $1.28.

Rafael (NYSE:RFL) last issued its quarterly earnings results on Monday, March 16th. The company reported ($0.13) EPS for the quarter. The firm had revenue of $0.21 million for the quarter. Rafael had a negative net margin of 2,846.60% and a negative return on equity of 37.27%.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.